Results for “absorption-ratio”

50 skills
More results
dromlakhani
esa-pa-interpret-sit
Interprets the saline infusion test (SIT) to assess the probability of primary aldosteronism when a patient has a positive aldosterone-to-renin ratio (ARR) and requires confirmatory testing. Triggers include evaluating post‑infusion plasma aldosterone concentration (PAC) after a positive ARR, hypertension work‑up, or when deciding whether to proceed to adrenal venous sampling (AVS).
10
dromlakhani
esa-pa-interpret-cct
Evaluates likelihood of primary aldosteronism by measuring plasma aldosterone suppression after oral captopril; normal suppression ≥30% makes PA unlikely, while lack of suppression with persistently suppressed plasma renin activity suggests PA. Use when assessing captopril challenge test (CCT) results for PA diagnosis in patients with positive aldosterone-to-renin ratio.
10
dromlakhani
jes-pa-screening-arr-arc
Interprets the aldosterone-to-renin ratio using active renin concentration (ARC) to screen for primary aldosteronism. Triggered when a clinician has PAC and ARC results and asks 'How do I interpret this ARR using active renin concentration?'
10
dromlakhani
esa-pa-interpret-avs
Determines unilateral vs bilateral aldosterone excess based on cortisol-corrected aldosterone ratios from adrenal venous sampling, with ratio >4:1 indicating unilateral excess, ratio 3:1 suggestive of bilateral hypersecretion, and interpretation dependent on cosyntropin stimulation protocol used during sampling. Use when analyzing AVS results to guide surgical vs medical treatment decisions; triggers include 'AVS lateralization ratio', 'cosyntropin-stimulated AVS', 'aldosterone-to-cortisol ratio >4:1', and 'ratio 3:1 suggestive of bilateral disease'.
10
dromlakhani
ata-adipsic-di-titration
Recommends careful DDAVP and fluid intake titration including frequent weighing and serum sodium level monitoring for adipsic diabetes insipidus. Use when managing adipsic DI requiring fluid balance management.
10
snoodleboot-io
prometheus-query-patterns
rate(http_requests_total[5m])
2
smith6jt-cop
large-cell-ratio-matching
MaxFuse parameter tuning for datasets with large protein:RNA cell ratios (>100:1)
3
dromlakhani
jes-pa-screening-arr-pra
Determines if PAC/PRA ratio and PAC levels indicate positive or provisionally positive screening for primary aldosteronism. Triggered when a clinician has PAC and PRA results and asks “Is this screening test positive for PA?” or needs to interpret borderline results.
10
iterationlayer
extract-recu-data
Extract receipt number, issuer, payer, date, VAT, and total from French receipts.
2
dromlakhani
endo-pharmaco-eligibility
Assess pharmacotherapy eligibility based on BMI/comorbidity
10
manojbajaj95
conversion-rate-optimization
Conversion rate optimization for marketing pages and lead-capture forms. Use when the user wants to improve conversions on a homepage, landing page, pricing page, feature page, blog CTA, contact form, demo form, or campaign page. For product onboarding use user-onboarding; for lifecycle email use marketing-automation; for pricing and paywalls use pricing-strategy; for A/B testing use ab-test-setup.
88
dromlakhani
esa-pa-interpret-18ohb
Differentiates aldosterone-producing adenoma from idiopathic adrenal hyperplasia based on 18-hydroxycorticosterone levels, with APA patients generally having levels >100 ng/dL at 8:00 a.m. and IAH patients usually having levels <100 ng/dL. Use when reviewing 18-OHB test results to help subtype PA; triggers include 18-OHB >100 ng/dL (suggesting APA) or <100 ng/dL (suggesting IAH).
10
oxoyo
abak-rule
融合潜能蒸馏与规则抽象能力,从规则维度提取和转化潜能,构建基于规则的潜能发展框架。
1 · bundle
dromlakhani
esa-pa-gra-gluco-dosing
Calculates the lowest effective glucocorticoid dose (dexamethasone or prednisone) to normalize blood pressure and serum potassium in glucocorticoid-remediable aldosteronism (GRA/FH-I) by titrating to biochemical and clinical targets. Indicated when initiating medical treatment for confirmed GRA, triggered by findings such as early-onset hypertension, family history of stroke before age 40, spontaneous hypokalemia, or suppressed plasma renin activity with elevated aldosterone.
10
dromlakhani
endo-ace-arb-ccb-htn
Recommends ACE inhibitors, ARBs, or calcium channel blockers as first-line hypertension therapy rather than β‑adrenergic blockers in obese patients with type 2 diabetes. Triggers include when a clinician asks, 'What antihypertensive should I start for this obese patient with T2DM to avoid weight gain?' or 'Should I avoid β‑blockers in this patient with diabetes and hypertension?'
10
dromlakhani
endo-oc-vs-injectable
Suggests oral contraceptives over injectable contraceptives for women with BMI ≥27 kg/m2 with comorbidities or BMI ≥30 kg/m2 seeking contraception, provided they are well‑informed and oral contraceptives are not contraindicated. Triggers include clinician questions such as “Which contraceptive method is less likely to cause weight gain in this obese patient?” or “Should I recommend oral pills instead of depot injection for this patient with BMI 29 and hypertension?”.
10
dromlakhani
endo-pa-mra-titrate-renin
In patients with primary aldosteronism receiving mineralocorticoid receptor antagonist therapy, the guideline recommends titrating the MRA dose upward to raise renin when blood pressure remains uncontrolled and renin is suppressed. Consider this step when hypertension is not at goal despite MRA therapy and plasma renin activity (or direct renin concentration) is low.
10
x3allamerican
da-refusal-vs-diluted-result
Use this skill when interpreting a drug test result that comes back as 'diluted negative,' 'diluted positive,' 'refusal,' or 'adulterated.' Covers what constitutes a refusal vs. retest vs. confirmed positive.
1
rootcastleco
clarity-gate
Pre-ingestion verification for epistemic quality in RAG systems with 9-point verification and Two-Round HITL workflow
6
alphagbm
alphagbm-take-profit
Quantifies whether a stock is suitable for long-term holding or requires tiered profit-taking using a novel 'rollercoaster rate' metric, running 15 exit strategies over ~10 years of daily history per ticker.
1.2k
theheavenlyd3mon
ingest
Team-Wiki Ingest
28
qhjqhj00
psnr
Evaluates the trade-off between file size reduction and image fidelity when encoding radio astronomy data using JPEG2000, benchmarking both lossless and lossy compression modes to determine the compression ratio at which visual artifacts first appear.
3
curiositech
alphago-deep-rl
Strategic patterns for solving intractable problems through cascading approximation, self-improvement, and heterogeneous evaluation from DeepMind's AlphaGo system
10 · bundle
dromlakhani
enda-stress-dose-hc-labor
Administer Hydrocortisone Stress Dosing During Active Phase of Labor
10
antigravity
form-cro
Optimize lead capture, contact, demo request, application, survey, quote, and checkout forms to maximize completion rates while preserving data usefulness.
42.4k
sinhoneyy
grants
NIH grant research skill for clinical researchers. Grill-me intake (research idea + career stage + preliminary data + environment + submission posture + known institute targets) locks down the funding strategy before any search runs. Runs a 5-facet Consensus positioning analysis (with draft Significance/Innovation language), maps the research to the right NIH institutes and study sections via RePORTER, finds NOSIs and funded overlap, and produces an editable Word document (.docx) with budget/scope-aware mechanism recommendations, submission timelines, and a mandatory program officer recommendation. Use when the user asks about research funding or makes any grant-related request (e.g., 'grants for [topic]', 'find grants for my research idea', 'what grants match my research', 'help me find NIH funding', 'grant opportunities for my research'). NIH-only scope — non-NIH funders (PCORI, DOD CDMRP, VA, foundations) are out of scope and flagged at intake.
11 · bundle
gtynnn060110-hash
analyzing-financial-statements
This skill calculates key financial ratios and metrics from financial statement data for investment analysis
6 · bundle
iterationlayer
extract-quittung-data
Extract receipt number, issuer, payer, date, VAT, and total from German receipts.
2
qhjqhj00
ast-eval
Benchmarks automatic speech translation and recognition on English-French and English-Romanian datasets, reporting BLEU and WER on tokenized outputs.
3
smith6jt-cop
differential-sharpe-ratio
Use when implementing risk-adjusted rewards, discussing Sharpe ratio in RL training, or tuning reward components for risk awareness
3
dromlakhani
ata-hc-dosing-regimen
Recommends hydrocortisone replacement dosing of 15–20 mg total daily, administered as a single dose or divided doses with the highest dose given in the morning upon awakening and the second dose in the afternoon (two-dose regimen) or second and third doses at lunch and late afternoon (three-dose regimen). Use when initiating glucocorticoid replacement for adrenal insufficiency; triggers include diagnosing adrenal insufficiency requiring glucocorticoid replacement.
10
dromlakhani
endo-sdm-antidepressant
Recommends a shared decision‑making process that provides patients with quantitative estimates of the expected weight effect of antidepressants to inform drug choice, also considering expected treatment length. Triggers include clinician questions such as ‘How should I discuss weight‑change risks with this patient starting an antidepressant?’ or ‘What tool can I use to show expected weight impact of sertraline vs bupropion?’.
10
dvcrn
scan
Provides a standardized interface for ingesting raw data across domains such as genomics, network analysis, document review, and spatial mapping, converting it into semantic vectors for agent use.
32
iterationlayer
extract-ryoshusho-data
Extract receipt number, issuer, payer, date, tax, and total from Japanese receipts.
2
dromlakhani
esa-pa-interpret-18oxo
Helps distinguish unilateral from bilateral adrenal disease based on 18-oxocortisol levels, which are typically higher in aldosterone-producing adenoma than idiopathic adrenal hyperplasia. Use when evaluating 18-oxocortisol results during PA workup to guide subtype classification after a positive ARR.
10